by
According to the Foreclaro Global Research, the
Global
Drug Discovery Services Market size was valued at USD 24.6 billion in 2025. The report “Global Drug Discovery Services Market
Segmentation By Drug Type (Small Molecules, Biologics), By Type (DMPK,
Biology Services, Medicinal Chemistry), By Therapeutic Area (Oncology, Cardiovascular
Diseases, Diabetes, Neurology, Respiratory Diseases, Others)- Industry Trends and Forecast to
2033” gives a
detailed insight into current market dynamics and provides analysis on future
market growth.
The global drug discovery services market is
witnessing rapid growth as pharmaceutical and biotechnology companies
increasingly outsource early-stage research to accelerate drug development,
reduce costs, and optimize resource allocation. Drug discovery services
encompass target identification, high-throughput screening, hit-to-lead and
lead optimization, and preclinical research, leveraging advanced technologies
such as artificial intelligence, machine learning, bioinformatics, and
cheminformatics. The market is driven by rising prevalence of chronic,
infectious, and rare diseases, increasing demand for novel therapeutics, and
growing investments in R&D by both private and public sectors. Contract
research organizations (CROs) are expanding capabilities to offer end-to-end
and hybrid drug discovery solutions, enabling faster timelines and improved
efficiency. North America leads the market due to the presence of major
biopharma companies, advanced research infrastructure, and technological
adoption, while Asia-Pacific is emerging as a high-growth region supported by
cost-effective research facilities, skilled talent, and increasing outsourcing
trends. Overall, innovation, collaborations, and technology integration are
expected to sustain long-term market growth.
Have any questions or need more information?
Click the link below to request a sample or make an inquiry before making your
purchase:
https://foreclaroglobalresearch.com/research-report/global-drug-discovery-services-market
Global Drug
Discovery Services Market Report Highlights
· Increasing
outsourcing of early-stage research by pharmaceutical and biotechnology
companies is driving strong demand for drug discovery services.
· Adoption
of AI, machine learning, bioinformatics, high-throughput screening, and
cheminformatics is enhancing efficiency in target identification, lead
optimization, and preclinical research.
· Growing
prevalence of chronic, infectious, and rare diseases is fueling the need for
innovative and faster drug development pipelines.
· Contract
research organizations (CROs) are offering end-to-end and hybrid drug discovery
services, enabling faster timelines and cost-effective solutions.
· North
America dominates due to advanced research infrastructure and presence of major
biopharma companies, while Asia-Pacific is emerging rapidly, driven by cost
advantages and skilled talent availability.
· Increased
collaborations, precision medicine approaches, integration of AI and
computational tools, and investment in novel therapeutics are expected to drive
sustained market growth.
Foreclaro
Global Research has segmented the Drug Discovery Services Market report based
on Drug Type, Type, Therapeutic Area, and region:
Drug
Discovery Services Market, Drug Type Outlook (Revenue - USD Million, 2020 -
2033)
Small
Molecules
Biologics
Drug
Discovery Services Market, Type Outlook (Revenue - USD Million, 2020 - 2033)
DMPK
Biology
Services
Medicinal
Chemistry
Drug
Discovery Services Market, Therapeutic Area Outlook (Revenue - USD Million,
2020 - 2033)
Oncology
Cardiovascular
Diseases
Diabetes
Neurology
Respiratory
Diseases
Others
Drug
Discovery Services Market, Regional Outlook (Revenue - USD Million, 2020 -
2033)
North
America
·
United
States
·
Canada
·
Mexico
Europe
·
United
Kingdom
·
Germany
·
France
·
Spain
·
Italy
·
Rest
of Europe
Asia
Pacific
·
China
·
India
·
Japan
·
Australia
·
South
Korea
·
Rest
of Asia Pacific
Latin
America
·
Brazil
·
Argentina
·
Rest
of Latin America
Middle East
& Africa
·
Saudi
Arabia
·
South
Africa
·
Rest
of MEA
Global Drug Discovery Services Market Key Players
·
Abbott Laboratories Inc.
·
Advinus Therapeutics
·
Agilent Technologies Ubiquigent
·
Albany Molecular Research Inc.
·
AstraZeneca PLC
·
Aurigene
·
Bayer AG
·
Charles River Laboratories International
·
ChemBridge Corporation
·
Covance
